GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: Journal of Separation Science, Wiley, Vol. 44, No. 24 ( 2021-12), p. 4368-4375
    Abstract: Biosynthesis is a promising way to manufacture desired products, however, the purification of its final products is a tough work due to the huge amount of reaction matrix. Liquid stationary phase of high‐speed counter‐current chromatography could easily avoid the commonly disadvantages that occurred in traditional column chromatography in the field of biosynthesized products purification. This characteristic makes high‐speed counter‐current chromatography particularly applicable for final products separation in biosynthesis. In this study, the glycosylation products of Silybin B by one‐pot glycosylation were successfully purified by high‐speed counter‐current chromatography to show the applicability of high‐speed counter‐current chromatography for preparative separation of biosynthesis products. An optimized n ‐hexane/ethyl acetate/methanol/water (2:5:2:3, v/v/v/v ) system was applied in this study. As a result, four Silybin B glycosylation products, including 7 mg of Silybin B‐5‐O‐ β ‐D‐glucoside ( SG‐1 ), 12 mg of Silybin B‐3‐O‐ β ‐D‐glucoside ( SG‐2 ), 10 mg of Silybin B‐7‐O‐ β ‐D‐glucoside ( SG‐3 ), and 24 mg of Silybin B‐20‐O‐ β ‐D‐glucoside ( SG‐4 ), were simultaneously separated from 200 mg of glycosylation crude products, with the purity of 89.3, 95.2, 96.4, and 97.5%, respectively. Their structures were identified by spectroscopic analysis.
    Type of Medium: Online Resource
    ISSN: 1615-9306 , 1615-9314
    URL: Issue
    RVK:
    Language: English
    Publisher: Wiley
    Publication Date: 2021
    detail.hit.zdb_id: 2047990-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Frontiers in Pharmacology, Frontiers Media SA, Vol. 13 ( 2022-10-19)
    Abstract: Bufadienolide, an essential member of the C-24 steroid family, is characterized by an α-pyrone positioned at C-17. As the predominantly active constituent in traditional Chinese medicine of Chansu, bufadienolide has been prescribed in the treatment of numerous ailments. It is a specifically potent inhibitor of Na + /K + ATPase with excellent anti-inflammatory activity. However, the severe side effects triggered by unbiased inhibition of the whole-body cells distributed α1-subtype of Na + /K + ATPase, restrict its future applicability. Thus, researchers have paved the road for the structural alteration of desirable bufadienolide derivatives with minimal adverse effects via biotransformation. In this review, we give priority to the present evidence for structural diversity, MS fragmentation principles, anti-inflammatory efficacy, and structure modification of bufadienolides derived from toads to offer a scientific foundation for future in-depth investigations and views.
    Type of Medium: Online Resource
    ISSN: 1663-9812
    Language: Unknown
    Publisher: Frontiers Media SA
    Publication Date: 2022
    detail.hit.zdb_id: 2587355-6
    SSG: 15,3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...